10x Genomics, Inc.
Cash Flow Statement
| Line Item | FY2017 |
|---|---|
| Operating Activities | |
| Net Income | $-18.8M |
| Depreciation & Amortization | $4.3M |
| Depreciation | $4.3M |
| Amortization | — |
| Stock-Based Compensation | $1.7M |
| Net Cash from Operating Activities | $-10.7M |
| Investing Activities | |
| Capital Expenditures | $3.8M |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-3.8M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | $80.0K |
| Net Cash from Financing Activities | $20.6M |
| Net Change in Cash | $6.1M |
| Free Cash Flow | $-14.5M |